Form 4: BioAge Labs Director Vijay Satyanand Pande Reports Significant Share Purchases

Director Vijay Satyanand Pande reported the acquisition of BioAge Labs shares through indirect holdings across multiple funds.

Summary

• Vijay Satyanand Pande, a director at BioAge Labs, reported several transactions involving the acquisition of common stock.
• These transactions occurred between October 1, 2024, and October 3, 2024.
• The shares were acquired indirectly through various Andreessen Horowitz (AH) funds.
• On October 1, 2024, 126,793 shares were acquired at a weighted average price of $19.73.
• On October 2, 2024, 67,096 shares were acquired at a weighted average price of $19.73.
• On October 3, 2024, 25,306 shares were acquired at a weighted average price of $19.90.
• Following these transactions, the total number of shares indirectly beneficially owned by Pande through Andreessen Horowitz LSV Fund III, L.P. increased to 1,119,195.
• Pande also indirectly owns shares through AH Bio Fund I, L.P. (1,269,072 shares), AH Bio Fund III, L.P. (189,609 shares), and AH Bio Fund IV, L.P. (655,294 shares).
• Pande disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to the director's share purchases, indicating confidence in the company. However, it's important to note that these are indirect holdings through investment funds, and the director disclaims beneficial ownership except for his pecuniary interest.

Positives

• The director's purchases indicate confidence in the company's future prospects.
• The purchases were made at prices ranging from $19.49 to $20.00, suggesting a belief that the stock is undervalued at these levels.

Industry Context

Insider buying is often seen as a positive signal in the biotech industry, as it suggests that those with the most knowledge of the company's prospects are optimistic about its future.

Stakeholder Impact

• The reported transactions may positively influence shareholder sentiment.
• The increased holdings by a director could be perceived as a sign of confidence in the company's future performance.

Key Dates